Annual Shareholders Equity
$236.32 M
+$177.30 M+300.41%
December 31, 2023
Summary
- As of February 7, 2025, VYGR annual stockholders equity is $236.32 million, with the most recent change of +$177.30 million (+300.41%) on December 31, 2023.
- During the last 3 years, VYGR annual shareholders equity has risen by +$82.00 million (+53.14%).
- VYGR annual shareholders equity is now at all-time high.
Performance
VYGR Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$330.31 M
-$5.11 M-1.52%
September 30, 2024
Summary
- As of February 7, 2025, VYGR quarterly stockholders equity is $330.31 million, with the most recent change of -$5.11 million (-1.52%) on September 30, 2024.
- Over the past year, VYGR quarterly shareholders equity has increased by +$93.99 million (+39.77%).
- VYGR quarterly shareholders equity is now -3.10% below its all-time high of $340.89 million, reached on March 31, 2024.
Performance
VYGR Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
VYGR Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +300.4% | +39.8% |
| 3 y3 years | +53.1% | +459.7% |
| 5 y5 years | +408.8% | +459.7% |
VYGR Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +300.4% | -3.1% | +459.7% |
| 5 y | 5-year | at high | +300.4% | -3.1% | +459.7% |
| alltime | all time | at high | +6265.4% | -3.1% | >+9999.0% |
Voyager Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $330.31 M(-1.5%) |
| Jun 2024 | - | $335.42 M(-1.6%) |
| Mar 2024 | - | $340.89 M(+44.2%) |
| Dec 2023 | $236.32 M(+300.4%) | $236.32 M(+34.1%) |
| Sep 2023 | - | $176.22 M(-11.5%) |
| Jun 2023 | - | $199.03 M(-8.3%) |
| Mar 2023 | - | $216.96 M(+267.6%) |
| Dec 2022 | $59.02 M(-37.9%) | $59.02 M(-26.1%) |
| Sep 2022 | - | $79.82 M(+32.9%) |
| Jun 2022 | - | $60.05 M(-20.9%) |
| Mar 2022 | - | $75.93 M(-20.1%) |
| Dec 2021 | $95.06 M(-38.4%) | $95.06 M(+8.7%) |
| Sep 2021 | - | $87.42 M(-20.9%) |
| Jun 2021 | - | $110.54 M(-18.8%) |
| Mar 2021 | - | $136.21 M(-11.7%) |
| Dec 2020 | $154.32 M(+55.1%) | $154.32 M(-7.2%) |
| Sep 2020 | - | $166.24 M(+116.2%) |
| Jun 2020 | - | $76.88 M(-3.6%) |
| Mar 2020 | - | $79.76 M(-19.9%) |
| Dec 2019 | $99.51 M | $99.51 M(-8.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $108.16 M(-8.7%) |
| Jun 2019 | - | $118.40 M(+17.6%) |
| Mar 2019 | - | $100.69 M(+116.8%) |
| Dec 2018 | $46.45 M(-65.4%) | $46.45 M(-29.2%) |
| Sep 2018 | - | $65.59 M(-20.0%) |
| Jun 2018 | - | $81.97 M(-16.6%) |
| Mar 2018 | - | $98.29 M(-26.7%) |
| Dec 2017 | $134.05 M(-1.4%) | $134.05 M(+57.3%) |
| Sep 2017 | - | $85.21 M(-19.1%) |
| Jun 2017 | - | $105.29 M(-14.2%) |
| Mar 2017 | - | $122.70 M(-9.7%) |
| Dec 2016 | $135.92 M(-19.6%) | $135.92 M(-8.9%) |
| Sep 2016 | - | $149.12 M(-4.2%) |
| Jun 2016 | - | $155.70 M(-4.8%) |
| Mar 2016 | - | $163.60 M(-3.2%) |
| Dec 2015 | $169.07 M(>+9900.0%) | $169.07 M(+66.2%) |
| Sep 2015 | - | $101.72 M(-2.9%) |
| Jun 2015 | - | $104.72 M(+9013.6%) |
| Dec 2014 | $1.15 M(-130.0%) | $1.15 M |
| Dec 2013 | -$3.83 M | - |
FAQ
- What is Voyager Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Voyager Therapeutics?
- What is Voyager Therapeutics annual shareholders equity year-on-year change?
- What is Voyager Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Voyager Therapeutics?
- What is Voyager Therapeutics quarterly shareholders equity year-on-year change?
What is Voyager Therapeutics annual stockholders equity?
The current annual shareholders equity of VYGR is $236.32 M
What is the all time high annual shareholders equity for Voyager Therapeutics?
Voyager Therapeutics all-time high annual stockholders equity is $236.32 M
What is Voyager Therapeutics annual shareholders equity year-on-year change?
Over the past year, VYGR annual stockholders equity has changed by +$177.30 M (+300.41%)
What is Voyager Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of VYGR is $330.31 M
What is the all time high quarterly shareholders equity for Voyager Therapeutics?
Voyager Therapeutics all-time high quarterly stockholders equity is $340.89 M
What is Voyager Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, VYGR quarterly stockholders equity has changed by +$93.99 M (+39.77%)